Metropolis Healthcare, India’s second-largest and one of the most trusted pathology laboratory chains, organised a high-impact Scientific Symposium on Genomics. The event brought together more than 300 clinicians, researchers, scientists, and academicians to accelerate the clinical integration of genomic diagnostics within India’s healthcare ecosystem.
Unveiling the Centre of Genomics
During the symposium, Metropolis formally unveiled its Centre of Genomics to the clinician community. Through this initiative, the company strengthened its broader clinical engagement strategy aimed at embedding advanced molecular diagnostics into routine medical practice.
As precision medicine gains momentum both in India and globally, the forum underscored a significant shift—from episodic testing to integrated, molecular-driven care pathways. Consequently, clinicians can now pursue earlier diagnosis, more precise risk stratification, and personalised treatment across specialties such as oncology, neurology, and women and child health.
Advancing Oncology Through Molecular Profiling
In oncology-focused sessions, experts emphasised tumour profiling, biomarker-driven therapies, and the growing role of next-generation sequencing in guiding targeted cancer treatment. By leveraging genomic insights, clinicians can make more informed therapeutic decisions and tailor interventions to individual patient profiles.
Expanding the Scope of Neurogenomics
Meanwhile, neurogenomics discussions addressed inherited and rare neurological disorders, including genetic epilepsies and neuromuscular conditions. Experts demonstrated how genomic testing reduces diagnostic delays and supports personalised management strategies. As a result, patients with complex neurological presentations can receive earlier and more accurate diagnoses.
Strengthening Women and Child Health
In the domain of women and child health, specialists explored reproductive genomics, prenatal diagnostics, and genetic counselling. They highlighted how early molecular insights improve pregnancy outcomes and enhance paediatric care. Furthermore, integrating genomic data into obstetric and paediatric workflows allows clinicians to anticipate and manage risks proactively.
Interactive Sessions and Multidisciplinary Dialogue
As reported by Pharmabiz, the symposium featured parallel sub-specialty sessions led by key opinion leaders, medical advisory board members, and distinguished national and international speakers. Through panel discussions and case-based deliberations, participants deepened cross-disciplinary collaboration and strengthened clinical engagement.
Clinicians also presented real-world case studies illustrating how genomics enables a shift from symptomatic management to evidence-based, targeted interventions. These examples reflected a broader transition toward longitudinal, data-driven diagnostic journeys that support continuous and personalised patient care.
Leadership Perspective on Precision Medicine
Ameera Shah, Promoter and Executive Chairperson of Metropolis Healthcare Limited, emphasised the importance of embedding genomic intelligence into everyday clinical workflows. She stated that the future of healthcare depends on creating connected ecosystems where diagnostics, data science, and clinical expertise function seamlessly together. According to her, the organisation aims to integrate molecular intelligence into routine decision-making so that precision medicine becomes the standard of care rather than the exception.
Ensuring Accuracy and Responsible Scaling
Dr. Kirti Chadha, Chief Scientific and Innovation Officer at Metropolis Healthcare, highlighted that the primary challenge in genomic medicine is not technological access but ensuring accuracy, interpretation, and accountability. She stressed that responsible scaling requires rigorous validation frameworks, structured reporting standards, and close collaboration between scientists and clinicians. Only through such coordinated efforts, she noted, can genomic findings translate into clear, confident, and clinically meaningful patient care decisions.